Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

ClinicalTrials.gov ID: NCT05360446

Public ClinicalTrials.gov record NCT05360446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)

Study identification

NCT ID
NCT05360446
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
610 participants

Conditions and interventions

Interventions

  • Inclisiran sodium 300 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 7, 2022
Primary completion
Oct 25, 2026
Completion
Oct 25, 2026
Last update posted
Apr 13, 2026

2022 – 2026

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Heart Center Research Llc Huntsville Alabama 35801
Alaska Heart and Vascular Anchorage Alaska 99508
Cardiovascular Res Found Beverly Hills California 90210
UC San Diego Health La Jolla California 92037
Stanford Health Care Stanford California 94305
Lundquist Inst BioMed at Harbor Torrance California 90509-2910
Bridgeport Hospital Bridgeport Connecticut 06610
George Washington Univ Medical Ctr Washington D.C. District of Columbia 20037
Inpatient Research Clinical LLC Miami Lakes Florida 33014
NorthShore University Health System Evanston Illinois 60201
Reid Physician Associates Richmond Indiana 47374
Midwest Heart and Vascular Spec Overland Park Kansas 66211
Anderson Medical Research Ft. Washington Maryland 20744
Minneapolis Heart Institute Minneapolis Minnesota 55407
R Ins For Heart And Vascular Health Reno Nevada 89502
Cardio Metabolic Institute Somerset New Jersey 08873
Icahn School of Med at Mt Sinai New York New York 10029
State Uni of NY at Stony Brook Stony Brook New York 11794-3362
Westchester Medical Center Valhalla New York 10595
Aultman Hospital Canton Ohio 44710
Oregon Health Sciences University Portland Oregon 97239
Soltero Cardiovascular Research Center Dallas Texas 75226
Orion Medical Houston Texas 77034
Inova Fairfax Hospital Falls Church Virginia 22042
Virginia Heart Falls Church Virginia 22042
Swedish Medical Center-Cardiovascular Research Seattle Washington 98122
Univ of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05360446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05360446 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →